BREAKING: Nasdaq has approved the listing of Canary Capital's Staked INJ ETF — the first US-listed staked product for Injective. The fund will trade under ticker INJC and stake at least 90% of its INJ holdings, with a 1.10% sponsor fee. INJ surged around 10% in 24 hours to near $8.40, leading the CoinDesk 100 gainers. Trading still awaits the S-1 going effective with the SEC. #Injective #INJ #ETF #CryptoNews #Nasdaq #Staking #DeFi #Bitcoin #Ethereum #Zimbuck